Nutranomics, Inc. (NNRX)
- Previous Close
0.0000 - Open
0.0000 - Bid --
- Ask --
- Day's Range
0.0000 - 0.0000 - 52 Week Range
0.0000 - 0.0001 - Volume
1,000 - Avg. Volume
0 - Market Cap (intraday)
16,324 - Beta (5Y Monthly) 1.97
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0100 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Nutranomics, Inc. engages in the research, development, and sale of nutritional food products. It offers approximately 480 nutritional supplements, including formulating vitamin, mineral, herbal, and probiotic supplements. The company provides Nutritional Blood Analysis, a tool to examine the customer's blood cells on a video monitor, live, in real time; and the patented Assimilation Enhancing System that improves the absorption of nutrients. In addition, it offers educational services, including various types of analyses, trainings, certifications, and group presentations to individuals and industry professionals. The company distributes its products through sales representatives throughout North America and Asia, as well as through retail stores. Nutranomics, Inc. has a strategic partnership with Terra-Formance, LLC. The company was founded in 1995 and is headquartered in Salt Lake City, Utah.
www.nutranomics.com1
Full Time Employees
July 31
Fiscal Year Ends
Sector
Recent News: NNRX
Performance Overview: NNRX
Trailing total returns as of 4/24/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: NNRX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: NNRX
Valuation Measures
Market Cap
816.23k
Enterprise Value
816.23k
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
0.52
Enterprise Value/EBITDA
-0.55
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
25.93k
Diluted EPS (ttm)
-0.0100
Balance Sheet and Cash Flow
Total Cash (mrq)
34
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--
Company Insights: NNRX
NNRX does not have Company Insights